Teleflex Incorporated vs Abbvie Inc.
TFX vs ABBV — side-by-side comparison from reported financials. TFX leads 3, ABBV leads 9 of 12 comparable metrics.
Teleflex Incorporated
TFX · Healthcare
$125.12+0.75%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | TFX | ABBV |
|---|---|---|
| Price | $125.12 | $276.43 |
| Market cap | $5.30B | $488B |
| Revenue (TTM) | $6.05B | $64.4B |
| Revenue growth | -10.6% | +1.8% |
| Net margin | -16.7% | 9.8% |
| Free cash flow | $229M | $18.2B |
| Net cash (debt) | ($2.61B) | ($56.2B) |
| 1-year price return | +0.3% | +19.8% |
| P/E | 28.7 | 77.4 |
| P/E vs own history (cheap-side %) | 64% | 23% |
| Dividend yield | 1.13% | 2.45% |
| Return on equity | -32% | 96% |
| Altman Z-score | 1.93 | 2.33 |
| CV checks passed | 8 of 11 | 9 of 11 |
| Employees | 15,500 | 57,000 |
Full résumé-style profiles: TFX CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.